KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Total Current Liabilities (2016 - 2025)

Novartis Ag's Total Current Liabilities history spans 12 years, with the latest figure at $27.3 billion for Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 4.93% to $27.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $27.3 billion, a 4.93% decrease, with the full-year FY2025 number at $27.3 billion, down 4.93% from a year prior.
  • Total Current Liabilities hit $27.3 billion in Q4 2025 for Novartis Ag, down from $31.7 billion in the prior quarter.
  • Over the last five years, Total Current Liabilities for NVS hit a ceiling of $31.9 billion in Q2 2023 and a floor of $25.2 billion in Q2 2021.
  • Historically, Total Current Liabilities has averaged $28.5 billion across 5 years, with a median of $28.2 billion in 2022.
  • Biggest five-year swings in Total Current Liabilities: increased 15.42% in 2023 and later fell 13.47% in 2024.
  • Tracing NVS's Total Current Liabilities over 5 years: stood at $30.2 billion in 2021, then decreased by 5.14% to $28.7 billion in 2022, then dropped by 7.91% to $26.4 billion in 2023, then grew by 8.72% to $28.7 billion in 2024, then fell by 4.93% to $27.3 billion in 2025.
  • Business Quant data shows Total Current Liabilities for NVS at $27.3 billion in Q4 2025, $31.7 billion in Q2 2025, and $28.7 billion in Q4 2024.